Publicaciones en las que colabora con José Tuñón Fernández (32)

2024

  1. Cardiac Rehabilitation Increases Plasma Klotho Levels

    Journal of Clinical Medicine, Vol. 13, Núm. 6

  2. Fibroblast growth factor 23 independently predicts adverse outcomes after an acute coronary syndrome

    ESC Heart Failure, Vol. 11, Núm. 1, pp. 240-250

2023

  1. Absence of High Lipoprotein(a) Levels Is an Independent Predictor of Acute Myocardial Infarction without Coronary Lesions

    Journal of Clinical Medicine, Vol. 12, Núm. 3

2022

  1. Impact of renal function on the prognostic value of mineral metabolism in patients with chronic ischaemic heart disease patients with chronic ischaemic heart disease

    Clinica e Investigacion en Arteriosclerosis, Vol. 34, Núm. 1, pp. 1-9

  2. NT-proBNP Levels Influence the Prognostic Value of Mineral Metabolism Biomarkers in Coronary Artery Disease

    Journal of Clinical Medicine, Vol. 11, Núm. 14

2021

  1. Beta-blocker therapy in elderly patients with renal dysfunction and heart failure

    Journal of Geriatric Cardiology, Vol. 18, Núm. 1, pp. 20-29

  2. Mcp-1 predicts recurrent cardiovascular events in patients with persistent inflammation

    Journal of Clinical Medicine, Vol. 10, Núm. 5, pp. 1-13

  3. N-terminal pro-brain natriuretic peptide plasma levels are associated with intermediate-term follow-up cancer in coronary patients

    Journal of Clinical Medicine, Vol. 10, Núm. 18

  4. PCSK9 and HS-CRP Predict Progression of Aortic Stenosis in Patients with Stable Coronary Artery Disease

    Journal of Cardiovascular Translational Research, Vol. 14, Núm. 2, pp. 238-245

  5. Parathormone levels add prognostic ability to N-terminal pro-brain natriuretic peptide in stable coronary patients

    ESC Heart Failure, Vol. 8, Núm. 4, pp. 2713-2722

  6. Prognostic value of initial QRS analysis in anterior STEMI: Correlation with left ventricular systolic dysfunction, serum biomarkers, and cardiac outcomes

    Annals of Noninvasive Electrocardiology, Vol. 26, Núm. 1

2020

  1. Galectin-3 is associated with cardiovascular events in post-acute coronary syndrome patients with type-2 diabetes

    Journal of Clinical Medicine, Vol. 9, Núm. 4

  2. Monocyte chemoattractant protein-1 is an independent predictor of coronary artery ectasia in patients with acute coronary syndrome

    Journal of Clinical Medicine, Vol. 9, Núm. 9, pp. 1-13

2017

  1. Cardiovascular efficacy and safety of bococizumab in high-risk patients

    New England Journal of Medicine, Vol. 376, Núm. 16, pp. 1527-1539

  2. Comparison of 3 predictive clinical risk scores in 603 patients with stable coronary artery disease

    Texas Heart Institute Journal, Vol. 44, Núm. 4, pp. 239-244

  3. Sun exposure influences the prognostic power of components of mineral metabolism in patients with coronary artery disease

    Nutrition, Metabolism and Cardiovascular Diseases, Vol. 27, Núm. 9, pp. 762-767

  4. Use of proton-pump inhibitors predicts heart failure and death in patients with coronary artery disease

    PLoS ONE, Vol. 12, Núm. 1

2016

  1. Circulating fibroblast growth factor-23 plasma levels predict adverse cardiovascular outcomes in patients with diabetes mellitus with coronary artery disease

    Diabetes/Metabolism Research and Reviews, Vol. 32, Núm. 7, pp. 685-693

  2. Important abnormalities of bone mineral metabolism are present in patients with coronary artery disease with a mild decrease of the estimated glomerular filtration rate

    Journal of Bone and Mineral Metabolism, Vol. 34, Núm. 5, pp. 587-598

2015

  1. Differential profile in inflammatory and mineral metabolism biomarkers in patients with ischemic heart disease without classical coronary risk factors

    Journal of Cardiology, Vol. 66, Núm. 1, pp. 22-27